SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Fiscal Quarter Ended January 26, 2003,
or
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Transition period from to .
Commission file number: 0-27446
LANDEC CORPORATION
(Exact name of registrant as specified in its charter)
California |
|
94-3025618 |
(State or other
jurisdiction of |
|
(IRS Employer |
|
|
|
3603 Haven Avenue |
||
(Address of principal executive offices) |
||
|
|
|
Registrants telephone number, including area code: |
||
(650) 306-1650 |
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. |
Yes |
ý |
No |
o |
|
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). |
Yes |
o |
No |
ý |
|
As of March 3, 2003, there were 21,107,517 shares of Common Stock and 157,726 shares of Convertible Preferred Stock, convertible into ten shares of Common Stock for each share of Preferred Stock, outstanding. |
LANDEC CORPORATION
FORM 10-Q For the Fiscal Quarter Ended January 26, 2003
|
|
|
|
|
|
|
|
|
|
|
|
a) Consolidated condensed balance sheets as of January 26, 2003 and October 27, 2002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Managements Discussion and Analysis of Financial Condition and Results of Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
LANDEC CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands)
|
|
January
26, |
|
October
27, |
|
||
|
|
(Unaudited) |
|
|
|
||
Assets |
|
|
|
|
|
||
Current Assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
5,339 |
|
$ |
7,849 |
|
Restricted cash |
|
2,382 |
|
1,032 |
|
||
Accounts receivable, less allowance for doubtful accounts of $837 and $1,022 at January 26, 2003 and October 27, 2002 |
|
14,722 |
|
19,040 |
|
||
Inventory |
|
17,266 |
|
10,121 |
|
||
Investment in farming activities |
|
700 |
|
1,591 |
|
||
Notes and advances receivable |
|
2,720 |
|
3,645 |
|
||
Notes receivable, related party |
|
|
|
751 |
|
||
Prepaid expenses and other current assets |
|
2,097 |
|
2,456 |
|
||
Total Current Assets |
|
45,226 |
|
46,485 |
|
||
|
|
|
|
|
|
||
Property and equipment, net |
|
19,202 |
|
19,902 |
|
||
Goodwill |
|
25,733 |
|
25,733 |
|
||
Other intangible assets, net |
|
11,732 |
|
11,747 |
|
||
Notes receivable |
|
1,465 |
|
1,132 |
|
||
Restricted cash, non-current |
|
|
|
1,350 |
|
||
Other assets |
|
296 |
|
1,454 |
|
||
|
|
|
|
|
|
||
|
|
$ |
103,654 |
|
$ |
107,803 |
|
|
|
|
|
|
|
||
Liabilities and Shareholders Equity |
|
|
|
|
|
||
Current Liabilities: |
|
|
|
|
|
||
Accounts payable |
|
$ |
10,362 |
|
$ |
11,512 |
|
Grower payables |
|
1,001 |
|
6,460 |
|
||
Related party payables |
|
174 |
|
450 |
|
||
Accrued compensation |
|
1,312 |
|
1,518 |
|
||
Other accrued liabilities |
|
4,314 |
|
7,771 |
|
||
Deferred revenue |
|
15,404 |
|
3,215 |
|
||
Lines of credit |
|
8,134 |
|
10,098 |
|
||
Current maturities of long term debt |
|
2,255 |
|
2,193 |
|
||
Total Current Liabilities |
|
42,956 |
|
43,217 |
|
||
|
|
|
|
|
|
||
Long term debt, less current maturities |
|
3,922 |
|
5,252 |
|
||
Other liabilities |
|
1,544 |
|
1,791 |
|
||
Minority interest |
|
1,158 |
|
1,580 |
|
||
Total Liabilities |
|
49,580 |
|
51,840 |
|
||
|
|
|
|
|
|
||
Shareholders Equity: |
|
|
|
|
|
||
Preferred stock |
|
5,420 |
|
14,461 |
|
||
Common stock |
|
110,098 |
|
100,802 |
|
||
Accumulated deficit |
|
(61,444 |
) |
(59,300 |
) |
||
Total Shareholders Equity |
|
54,074 |
|
55,963 |
|
||
|
|
|
|
|
|
||
|
|
$ |
103,654 |
|
$ |
107,803 |
|
See accompanying notes.
4
LANDEC CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
|
|
Three Months Ended |
|
||||
|
|
January
26, |
|
January
27, |
|
||
Revenues: |
|
|
|
|
|
||
Product sales |
|
$ |
34,203 |
|
$ |
32,924 |
|
Services revenue |
|
5,996 |
|
6,094 |
|
||
Service revenue, related party |
|
454 |
|
780 |
|
||
License fees |
|
272 |
|
427 |
|
||
Research, development and royalty revenues |
|
200 |
|
121 |
|
||
Total revenues |
|
41,125 |
|
40,346 |
|
||
|
|
|
|
|
|
||
Cost of revenue: |
|
|
|
|
|
||
Cost of product sales |
|
30,773 |
|
30,265 |
|
||
Cost of services revenue |
|
4,629 |
|
5,394 |
|
||
Total cost of revenue |
|
35,402 |
|
35,659 |
|
||
|
|
|
|
|
|
||
Gross profit |
|
5,723 |
|
4,687 |
|
||
|
|
|
|
|
|
||
Operating costs and expenses: |
|
|
|
|
|
||
Research and development |
|
1,070 |
|
832 |
|
||
Selling, general and administrative |
|
6,524 |
|
6,783 |
|
||
Total operating costs and expenses |
|
7,594 |
|
7,615 |
|
||
Operating loss |
|
(1,871 |
) |
(2,928 |
) |
||
|
|
|
|
|
|
||
Interest income |
|
64 |
|
33 |
|
||
Interest expense |
|
(322 |
) |
(631 |
) |
||
Other income |
|
93 |
|
5 |
|
||
Net loss |
|
$ |
(2,036 |
) |
$ |
(3,521 |
) |
|
|
|
|
|
|
||
Net loss |
|
$ |
(2,036 |
) |
$ |
(3,521 |
) |
Dividends on Series B preferred stock |
|
(108 |
) |
(100 |
) |
||
Net loss applicable to shareholders |
|
$ |
(2,144 |
) |
$ |
(3,621 |
) |
|
|
|
|
|
|
||
Basic and diluted net loss per share |
|
$ |
(0.10 |
) |
$ |
(0.22 |
) |
|
|
|
|
|
|
||
Shares used in computing basic and diluted net loss per share |
|
20,630 |
|
16,563 |
|
See accompanying notes.
5
LANDEC CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|
|
Three Months Ended |
|
||||||
|
|
January
26, |
|
January
27, |
|
||||
Cash flows from operating activities: |
|
|
|
|
|
||||
Net loss |
|
$ |
(2,036 |
) |
$ |
(3,521 |
) |
||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
|
||||
Depreciation and amortization |
|
879 |
|
741 |
|
||||
(Gain) loss on disposal of property and equipment |
|
(39 |
) |
59 |
|
||||
Increase in minority interest liability |
|
89 |
|
42 |
|
||||
Changes in current assets and liabilities: |
|
|
|
|
|
||||
Accounts receivable |
|
4,318 |
|
(2,473 |
) |
||||
Inventory |
|
(7,145 |
) |
(1,480 |
) |
||||
Investment in farming activities |
|
891 |
|
598 |
|
||||
Decrease in notes and advances receivable |
|
2,046 |
|
330 |
|
||||
Prepaid expenses and other current assets |
|
359 |
|
(126 |
) |
||||
Assets held for sale |
|
|
|
(55 |
) |
||||
Accounts payable |
|
(1,150 |
) |
1,229 |
|
||||
Grower payables |
|
(5,459 |
) |
413 |
|
||||
Related party payables |
|
(276 |
) |
203 |
|
||||
Accrued compensation |
|
(206 |
) |
371 |
|
||||
Other accrued liabilities |
|
(3,457 |
) |
(502 |
) |
||||
Deferred revenue |
|
12,189 |
|
13,152 |
|
||||
Total adjustments |
|
3,039 |
|
12,502 |
|
||||
Net cash provided by operating activities |
|
1,003 |
|
8,981 |
|
||||
|
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
|
|
||||
Change in other assets and liabilities |
|
891 |
|
124 |
|
||||
Purchases of property and equipment |
|
(808 |
) |
(1,285 |
) |
||||
Increase in restricted cash |
|
|
|
(14 |
) |
||||
Net cash provided by (used in) investing activities |
|
83 |
|
(1,175 |
) |
||||
|
|
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
|
|
||||
Proceeds from sale of common stock |
|
147 |
|
180 |
|
||||
Borrowings on lines of credit |
|
13,041 |
|
5,235 |
|
||||
Payments on lines of credit |
|
(15,005 |
) |
(12,466 |
) |
||||
Proceeds from issuance of long term debt |
|
|
|
34 |
|
||||
Payments on long term debt |
|
(1,268 |
) |
(1,883 |
) |
||||
Distributions to minority interest |
|
(511 |
) |
|
|
||||
Net cash used in financing activities |
|
(3,596 |
) |
(8,900 |
) |
||||
|
|
|
|
|
|
||||
Net decrease in cash and cash equivalents |
|
(2,510 |
) |
(1,094 |
) |
||||
|
|
|
|
|
|
||||
Cash and cash equivalents at beginning of period |
|
7,849 |
|
8,695 |
|
||||
|
|
|
|
|
|
||||
Cash and cash equivalents at end of period |
|
$ |
5,339 |
|
$ |
7,601 |
|
||
|
|
|
|
|
|
||||
Supplemental schedule of noncash investing and financing activities: |
|
|
|
|
|
||||
Sale of assets in exchange for a note receivable |
|
$ |
664 |
|
$ |
|
|
||
|
|
|
|
|
|
||||
Issuance of Series B preferred stock as dividends to Series B preferred stockholders |
|
$ |
108 |
|
$ |
100 |
|
||
|
|
|
|
|
|
||||
Conversion of Series A preferred stock into common stock |
|
$ |
9,149 |
|
$ |
|
|
||
See accompanying notes.
6
LANDEC CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
Landec Corporation and its subsidiaries (Landec or the Company) design, develop, manufacture, and sell temperature-activated and other specialty polymer products for a variety of food products, agricultural products, and licensed partner applications. The Company markets and distributes hybrid corn seed to farmers through its Landec Ag, Inc. (Landec Ag) subsidiary and specialty packaged fresh-cut vegetables and whole produce to retailers and foodservice companies primarily in the United States and Canada through its Apio, Inc. (Apio) subsidiary.
The accompanying unaudited consolidated financial statements of Landec Corporation (Landec or the Company) have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations, and cash flows at January 26, 2003, and for all periods presented, have been made. Although Landec believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in financial statements and related footnotes prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted per the rules and regulations of the Securities and Exchange Commission. The accompanying financial data should be reviewed in conjunction with the audited financial statements and accompanying notes included in Landecs Annual Report on Form 10-K for the fiscal year ended October 27, 2002.
The results of operations for the three month period ended January 26, 2003 are not necessarily indicative of the results that may be expected for an entire fiscal year. For instance, due to the cyclical nature of the corn seed industry, a significant portion of Landec Ag revenues and profits will be concentrated over a few months during the spring planting season (generally during Landecs second fiscal quarter).
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting period. Actual results could differ materially from those estimates.
For instance, the carrying value of notes and advances receivable, as well as investments in farming activities, are impacted by current market prices for the related crops, weather conditions and the fair value of the underlying security obtained by the Company, such as, liens on property and crops. The Company recognizes losses when it estimates that the fair value of the related crops or security is insufficient to cover the advance, note receivable or investment.
Reclassifications
Certain reclassifications have been made to prior period financial statements to conform to the current period presentation.
7
2. Recent Pronouncements
In August 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 143 (SFAS 143), Accounting for Asset Retirement Obligations. SFAS 143 addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and the associated retirement costs. On October 28, 2002, the Company adopted SFAS 143. The adoption of SFAS 143 did not have a material impact on the Company's results of operations or financial position.
3. Net Income Per Diluted Share
The computation of diluted net loss per share for the three months ended January 26, 2003 excludes the impact of options to purchase 112,052 shares of common stock and the conversion of the Convertible Preferred Stock, which is convertible into 1.5 million shares of common stock at January 26, 2003, as such impact would be antidilutive for this period.
The computation of diluted net loss per share for the three months ended January 27, 2002 excludes the impact of options to purchase 209,227 shares of common stock and the conversion of the Convertible Preferred Stock, which was convertible into 3.2 million shares of common stock at January 27, 2002, as such impact would be antidilutive for this period.
4. Goodwill and Other Intangibles
In June 2001, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 141, Business Combinations, and No. 142 (SFAS 142), Goodwill and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. The Company has applied the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of fiscal year 2002.
Under SFAS 142 the Company is required to review goodwill and indefinite lived intangible assets at least annually. In May 2002, the Company completed its initial impairment review upon adoption of SFAS 142, and in October 2002, the Company completed its annual review. The review is performed by grouping the net book value of all long-lived assets for acquired businesses, including goodwill and other intangible assets, and comparing this value to the related estimated fair value. The determination of fair value is based on estimated future discounted cash flows related to these long-lived assets. The discount rate used was based on the risks associated with the acquired businesses. The determinations of fair value were performed by an independent appraiser. The reviews concluded that the fair value of the acquired businesses exceeded the carrying value of their net assets and thus no impairment charge was warranted as of either May 2002 or October 2002.
5. Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or market and consisted of the following (in thousands):
|
|
January
26, |
|
October
27, |
|
||
Finished goods |
|
$ |
13,557 |
|
$ |
5,119 |
|
Raw material |
|
3,820 |
|
3,830 |
|
||
Work in process |
|
233 |
|
1,450 |
|
||
Gross inventory |
|
17,610 |
|
10,399 |
|
||
Less reserves |
|
(344 |
) |
(278 |
) |
||
|
|
|
|
|
|
||
Net inventory |
|
$ |
17,266 |
|
$ |
10,121 |
|
8
6. Debt
On October 31, 2002, Apios loan agreement with Bank of America was amended to extend the revolving line of credit through January 31, 2003 and to decrease the interest rate to prime plus 1.75%, or 6.00%, on an annual basis. The loan agreement was amended again in January 2003, and February 2003, resulting in an extension of the line of credit through May 1, 2003. The Company is currently negotiating a new working capital line of credit with its bank.
7. Sale of Assets
On December 17, 2002, the Company sold fruit processing equipment and the rights to the Companys Great Whites trademark for $707,000, resulting in a net gain of $39,000. The purchase price will be paid in equal annual installments over the next seven years. In addition, the Company entered into a supply agreement with the purchaser to supply fruit to the Companys export business for the next three years with an option for year four.
8. Related Party
In May 2002, Apio advanced to a farm wholly-owned by the Chief Executive Officer of Apio (Apio CEO) $1.1 million for ground lease payments and crop financing expenses in order to maintain current levels of produce sourcing from his personal farm. The advance accrues interest at Apios interest rate per its Bank of America loan agreement. Of the $1.1 million, $400,000 was repaid on June 30, 2002. On January 2, 2003, the remaining amount due plus accrued interest totaling $751,000 was offset against the earnout liability owed to the Apio CEO.
9. Preferred Stock
On November 19, 2002, the Series A preferred stock was automatically converted into 1,666,670 shares of common stock pursuant to the Series A preferred stock agreement dated November 19, 1999.
10. Dividends
Holders of Series B Convertible Preferred Stock are entitled to cumulative dividends payable in additional shares of Series B Convertible Preferred Stock at an annual rate of eight percent (8%) for the first two years, ten percent (10%) for the third year and twelve percent (12%) thereafter, following the initial sale on October 25, 2001, of shares of Series B Convertible Preferred Stock. Series B preferred stockholders were issued Series B preferred stock as accrued stock dividends of 3,093 shares on January 31, 2003. Dividends for Series B preferred stock are cumulative and were declared by the Companys Board of Directors and issued at a price of $35 per share as per the agreement.
9
11. Business Segment Reporting
Landec operates in two business segments: the Food Products Technology segment and the Agricultural Seed Technology segment. The Food Products Technology segment markets and packs produce and specialty packaged whole and fresh-cut vegetables that incorporate the Intelimerâ based breathable membrane for the retail grocery, club store and food services industry. The Agricultural Seed Technology segment markets and distributes hybrid seed corn to the farming industry and is developing seed coatings using Landecs proprietary Intelimer polymers. The Food Products Technology and Agricultural Seed Technology segments include charges for corporate services allocated from the Corporate and Other segment. Corporate and other amounts include non-core operating activities and corporate operating costs. All of the assets of the Company are located within the United States of America.
Operations by Business Segment (in thousands):
|
|
Food Products |
|
Agricultural |
|
Corporate |
|
TOTAL |
|
||||
Quarter ended January 26, 2003 |
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
$ |
40,588 |
|
$ |
64 |
|
$ |
473 |
|
$ |
41,125 |
|
International sales |
|
$ |
8,050 |
|
$ |
|
|
$ |
|
|
$ |
8,050 |
|
Gross profit |
|
$ |
5,243 |
|
$ |
8 |
|
$ |
472 |
|
$ |
5,723 |
|
Net income (loss) |
|
$ |
(160 |
) |
$ |
(2,184 |
) |
$ |
308 |
|
$ |
(2,036 |
) |
Interest expense |
|
$ |
259 |
|
$ |
63 |
|
$ |
|
|
$ |
322 |
|
Interest income |
|
$ |
54 |
|
$ |
|
|
$ |
10 |
|
$ |
64 |
|
Depreciation and amortization |
|
$ |
720 |
|
$ |
117 |
|
$ |
42 |
|
$ |
879 |
|
|
|
|
|
|
|
|
|
|
|
||||
Quarter ended January 27, 2002 |
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
$ |
39,184 |
|
$ |
614 |
|
$ |
548 |
|
$ |
40,346 |
|
International sales |
|
$ |
9,246 |
|
$ |
|
|
$ |
|
|
$ |
9,246 |
|
Gross profit |
|
$ |
3,916 |
|
$ |
223 |
|
$ |
548 |
|
$ |
4,687 |
|
Net income (loss) |
|
$ |
(2,443 |
) |
$ |
(1,739 |
) |
$ |
661 |
|
$ |
(3,521 |
) |
Interest expense |
|
$ |
567 |
|
$ |
64 |
|
$ |
|
|
$ |
631 |
|
Interest income |
|
$ |
33 |
|
$ |
|
|
$ |
|
|
$ |
33 |
|
Depreciation and amortization |
|
$ |
559 |
|
$ |
129 |
|
$ |
53 |
|
$ |
741 |
|
During the first three months of fiscal year 2003, sales to the Companys top five customers accounted for approximately 42% of revenues, with the Companys top customers from the Food Products Technology segment, Wal-Mart Stores Inc., accounting for approximately 19% and Costco Wholesale Corp., accounting for approximately 13% of revenues. The Company expects that, for the foreseeable future, a limited number of customers may continue to account for a significant portion of its net revenues.
12. Subsequent Events
On February 20, 2003, the Board of Directors of the Company approved a change in the Companys fiscal year end from a fiscal year including 52 or 53 weeks that ends on the last Sunday in October to a fiscal year including 52 or 53 weeks that ends on the last Sunday in May. As a result, the Companys fiscal year end for 2003 will be for the seven months ended May 25, 2003.
10
MANAGEMENTS DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the unaudited consolidated financial statements and accompanying notes included in Part IItem 1 of this Form 10-Q and the audited consolidated financial statements and accompanying notes and Managements Discussion and Analysis of Financial Condition and Results of Operations included in Landecs Annual Report on Form 10-K for the fiscal year ended October 27, 2002.
Except for the historical information contained herein, the matters discussed in this report are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Potential risks and uncertainties include, without limitation, those mentioned in this report and, in particular the factors described below under Additional Factors That May Affect Future Results, and those mentioned in Landecs Annual Report on Form 10-K for the fiscal year ended October 27, 2002. Landec undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this report.
Critical Accounting Policies and Use of Estimates
Use of Estimates
The preparation of the Companys financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. The judgements and assumptions used by management are based on historical experience and other factors, which are believed to be reasonable under the circumstances.
Notes and Advances Receivables
Apio has made advances to fruit growers for the development of orchards, and to produce growers for crop and harvesting costs. Typically, except for development advances, these advances are paid off within the growing season (less than one year) from harvested crops. Development advances and advances not fully paid during the current growing season are converted to interest bearing obligations, evidenced by contracts and notes receivable. These notes receivable and advances are secured by perfected liens on land and/or crops and have terms that range from twelve to sixty months. Notes receivable are periodically reviewed (at least quarterly) for collectibility. A reserve is established for any note or advance deemed to not be fully collectible based upon an estimate of the crop value or the fair value of the security for the note or advance. If crop prices or the fair value of the underlying security declines the Company may be unable to fully recoup its investment and the estimated losses would rise in the current period, potentially to the extent of the total investment.
Investments in Farming Activities
Investments in farming activities consist of cash advances to growers for expenses to be incurred during the growing season, in exchange for a percentage ownership in the proceeds of the crops. Net income or loss is generally recognized on these investments based on the Companys percentage ownership of the net proceeds of the crops as fields are harvested and proceeds are settled. These investments are periodically reviewed for impairment (at least quarterly). Additionally, certain farming agreements contain provisions wherein the Company bears the risk of loss if the net proceeds from the crops are not sufficient to cover the expense incurred. If crop prices decline the Company may be unable to fully recoup its investment and the estimated losses would rise in the current period, potentially to the extent of the total investment.
11
Allowance for Doubtful Accounts
The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The allowance for doubtful accounts is based on review of the overall condition of accounts receivable balances and review of significant past due accounts. If the financial condition of the Companys customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Bad debt losses are partially mitigated due to low risks related to the fact that the Companys customers are predominantly large financially sound national and regional retailers and because the Company carries foreign credit insurance to cover a portion of its foreign receivables exposure.
Inventories
Inventories are stated at the lower of cost or market. If the cost of the inventories exceeds their expected market value, provisions are recorded currently for the difference between the cost and the market value. These provisions are determined based on specific identification for unuseable inventory and a general reserve, based on historical losses, for inventory considered to be useable.
Revenue Recognition
Revenue from product sales is recognized when there is persuasive evidence that an arrangement exists, delivery has occurred, the price is fixed and determinable, and collectibility is reasonably assured. Allowances are established for estimated uncollectible amounts, product returns, and discounts. If actual future returns and allowances differ from past experience, additional allowances may be required.
Licensing revenue is recognized in accordance with Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements. Initial license fees are deferred and amortized over the period of the agreement to revenue when a contract exists, the fee is fixed and determinable, and collectibility is reasonably assured. Noncancellable, nonrefundable license fees are recognized over the research and development period of the agreement, as well as the term of any related supply agreement entered into concurrently with the license when the risk associated with commercialization of a product is non-substantive at the outset of the arrangement.
Contract revenue for research and development (R&D) is recorded as earned, based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and there is no continuing involvement by the Company, are recognized on the earlier of when the payments are received or when collection is assured.
12
The Company
Landec Corporation and its subsidiaries (Landec or the Company) design, develop, manufacture and sell temperature-activated and other specialty polymer products for a variety of food products, agricultural products, and licensed partner applications. This proprietary polymer technology is the foundation, and a key differentiating advantage, upon which we have built our business.
Landecs core polymer products are based on its patented proprietary Intelimer polymers, which differ from other polymers in that they can be customized to abruptly change their physical characteristics when heated or cooled through a pre-set temperature switch. For instance, Intelimer polymers can change within the range of one or two degrees Celsius from a non-adhesive state to a highly tacky, adhesive state; from an impermeable state to a highly permeable state; or from a solid state to a viscous state. These abrupt changes are repeatedly reversible and can be tailored by Landec to occur at specific temperatures, thereby offering substantial competitive advantages in Landecs target markets.
Landec has two core businesses Food Products Technology and Agricultural Seed Technology, in addition to our Technology Licensing/Research and Development business.
Our Food Products Technology business is operated through a subsidiary, Apio, Inc., and combines our proprietary food packaging technology with the capabilities of a large national food supplier and value-added produce processor. Value-added processing incorporates Landecs proprietary packaging technology with produce that is processed by washing, and in some cases cutting and mixing, resulting in packaged produce which can increase shelf life, reduce shrink (waste) and eliminates the need for ice during the distribution cycle. This combination was consummated in December 1999 when the Company acquired Apio, Inc. and certain related entities (collectively, Apio).
Our Agricultural Seed Technology business is operated through a subsidiary, Landec Ag, Inc., (Landec Ag) and combines our proprietary Intellicoat® seed coating technology with our unique eDC e-commerce, direct marketing and consultative selling capabilities which we obtained when we acquired Fielders Choice Direct (Fielders Choice), a direct marketer of hybrid seed corn, in September 1997.
In addition to our two core businesses, the Company also operates a Technology Licensing/Research and Development business that licenses products outside of our core businesses to industry leaders such as Alcon Laboratories, Inc. and UCB Chemicals, a subsidiary of UCB S.A. of Belgium.
Landec has been unprofitable during each fiscal year since its inception, and may incur additional losses in the future. The amount of future net profits, if any, is highly uncertain and there can be no assurance that Landec will be able to reach or sustain profitability for an entire fiscal year. From inception through January 26, 2003, Landecs accumulated deficit was $61.4 million.
Landec was incorporated in California on October 31, 1986. We completed our initial public offering in 1996 and our common stock is listed on the Nasdaq National Market under the symbol LNDC. Our principal executive offices are located at 3603 Haven Avenue, Menlo Park, California 94025 and our telephone number is (650) 306-1650.
Description of Core Business
We participate in two core business segments Food Products Technology and Agricultural Seed Technology. In addition to these two core segments, we license technology and conduct ongoing research and development through our Technology Licensing/Research and Development Business.
13
Food Products Technology Business
We began marketing in early fiscal year 1996 our proprietary Intelimer-based breathable membranes for use in the fresh-cut produce packaging market, one of the fastest growing segments in the food industry. Our proprietary packaging technology when combined with produce that is processed by washing and in some cases cut and mixed, results in packaged produce with increased shelf life, reduced shrink (waste) and without the need for ice during the distribution cycle, this we refer to as our value-added products. In December 1999, we acquired Apio, our largest customer in the Food Products Technology business and one of the nations leading marketers and packers of produce and specialty packaged fresh-cut vegetables. Apio provides year-round access to produce, utilizes state-of-the-art fresh-cut produce processing technology and distributes to the top U.S. retail grocery chains and major club stores and has recently begun expanding its product offerings to the foodservice industry. Our proprietary Intelimer-based packaging business has been combined with Apio into a wholly owned subsidiary that retains the Apio, Inc. name. This vertical integration within the Food Products Technology business gives Landec direct access to the large and growing fresh-cut produce market.
Based in Guadalupe, California, Apio, when acquired in December 1999, consisted of two major businesses first, the fee-for-service selling and marketing of whole produce and second, the specialty packaged fresh-cut and whole value-added processed products that are washed and packaged in our proprietary packaging. The fee-for-service business historically included field harvesting and packing, cooling and marketing of vegetables and fruits on a contract basis for growers in Californias Santa Maria, San Joaquin and Imperial Valleys as well as in Arizona and Mexico. Apio currently has approximately 12,600 acres under contract, consisting of approximately 17 percent of the farmable land in the Santa Maria Valley. The fresh-cut value-added processing products business, developed within the last 6 years, sells a variety of fresh-cut vegetables to the top retail grocery chains representing over 8,700 retail and club stores. During the fiscal year ended October 27, 2002, Apio shipped more than 19 million cartons of produce to some 700 customers including leading supermarket retailers, wholesalers, foodservice suppliers and club stores throughout the United States and internationally, primarily in Asia.
There are five major distinguishing characteristics of Apio that provide competitive advantages in the Food Products Technology market:
Full Service Supplier: Apio has structured its business as a full service marketer and seller of vegetables, fruits, and fresh-cut value-added produce. It is focused on developing its Eat Smart® brand name for all of its value-added products. As retail grocery and club store chains consolidate, Apio is well positioned as a single source of a broad range of products.
Reduced Farming Risks: Apio reduces its farming risk by not taking ownership of farmland, and instead, contracts with growers for produce and charges for services that include cooling, shipping and marketing. The year-round sourcing of produce is a key component to both the traditional produce business as well as the value-added processing business.
Lower Cost Structure: Apio has strategically invested in the rapidly growing value-added business. Apios 49,000 square foot value-added processing plant is automated with state-of-the-art vegetable processing equipment. Virtually all of Apios value-added products utilize Landecs proprietary breathable membrane technology. Our strategy is to operate one large central processing facility in one of Californias largest, lowest cost growing regions (Santa Maria Valley) and use packaging technology to allow for the nationwide delivery of fresh produce products.
Export Capability: Apio is uniquely positioned to benefit from the growth in export sales to Asia and Europe over the next decade with its export business, CalEx. Through CalEx, Apio is currently one of the largest U.S. exporters of broccoli to Asia and has recently launched its iceless products to Asia using our packaging technology.
Expanded Product Line Using Technology: Apio, through the use of our proprietary breathable membrane technology, is in the early stages of changing selective categories of the whole produce business. Its introduction of iceless
14
packaging for broccoli crowns in November 2000 was the beginning of a conversion from the traditional packing and shipping of whole produce, which relied heavily on ice, to iceless products utilizing our packaging technology. New iceless packaging is available for various broccoli products and green onions.
Agricultural Seed Technology Business
The Company formed our Landec Ag (formerly Intellicoat Corporation) subsidiary in 1995. Landec Ags strategy is to build a vertically integrated seed technology company based on the proprietary Intellicoat seed coating technology and its eDCe-commerce, direct marketing and consultative selling capabilities.
Landec Ag is conducting field trials using Intellicoat seed coatings, an Intelimer-based agricultural material designed to control seed germination timing, increase crop yields and extend crop planting windows. These coatings are initially being applied to corn and soybean seeds. According to the U.S. Agricultural Statistics Board, the total planted acreage in 2002 in the United States for corn and soybean seed exceeded 78.9 million and 73.0 million, respectively.
In fiscal year 2000, Landec Ag successfully launched its first commercial product, Pollinator Plus coatings for inbred corn seed. As a result of the success realized in fiscal year 2001, we expanded our sales of inbred corn seed coating products in fiscal year 2002 to regional and national seed companies in the United States. This application is targeted to approximately 640,000 acres in ten states and is now being used by over 30 seed companies in the United States. In addition, based on the successful field trial results during 2001 for our Early Plant hybrid coated corn, we expanded our sales in 2002. Our Relay Intercropping of wheat and soybean will allow farmers to plant and harvest two crops during the year on the same land, providing significant financial benefit for the farmer. Early Plant hybrid corn, perhaps Landec Ags largest seed coating opportunity, allows the farmer to plant corn seed 3 to 4 weeks earlier than typically possible due to cold soil temperatures. By allowing the farmer to plant earlier than normal, Early Plant hybrid corn will enable large farmers to utilize staff and equipment more efficiently and provide flexibility during the critical planting period. Recent market research with farmers in seven corn growing states verified that farmers would pay a significant premium for Landec Ags Early Plant hybrid corn product if they were able to plant a portion of their acreage up to one month early.
In September 1997, Landec Ag acquired Fielders Choice, a direct marketer of hybrid seed corn to farmers. Based in Monticello, Indiana, Fielders Choice offers a comprehensive line of corn hybrids to more than 14,000 farmers in over forty states through direct marketing programs. The success of Fielders Choice comes, in part, from its expertise in selling directly to the farmer, bypassing the traditional and costly farmer-dealer system. We believe that this direct channel of distribution provides up to a 35% cost advantage to its farmers.
In order to support its direct marketing programs, Fielders Choice has developed a proprietary e-commerce direct marketing, and consultative selling information technology, called eDC, that enables state-of-the-art methods for communicating with a broad array of farmers. This proprietary direct marketing information technology includes a current database of over 90,000 farmers. In August 1999, we launched the seed industrys first comprehensive e-commerce website. This website furthers our ability to provide a high level of consultation to Fielders Choice customers, backed by a six day a week call center capability that enables us to use the internet as a natural extension of our direct marketing strategy.
We believe our technology has commercial potential in a wide range of industrial, consumer and medical applications beyond those identified in its core businesses. For example, our core patented technology Intelimer materials, can be used to trigger release of small molecule drugs, catalysts, pesticides or fragrances just by changing the temperature of the Intelimer materials or to activate adhesives through controlled temperature change. In order to exploit these opportunities, we have entered into and will enter into licensing and collaborative corporate agreements for product development and/or distribution in certain fields.
15
Results of Operations
Total revenues were $41.1 million for the first quarter of fiscal year 2003 compared to $40.3 million for the first quarter of fiscal year 2002. Revenues from product sales and services increased to $40.7 million in the first quarter of fiscal year 2003 from $39.8 million in the first quarter of fiscal year 2002. The increase in product sales and service revenues was primarily due to revenue increases in Apios value-added specialty packaging business. Value-added revenues increased to $25.4 million in the first quarter of fiscal year 2003 from $20.9 million in the same period of fiscal year 2002. Revenues from license fees decreased to $272,000 for the first quarter of fiscal year 2003 from $427,000 for the first quarter of fiscal year 2002. The decrease was due to two months of revenue from the $2.0 million licensing agreement with UCB Chemicals Corporation that was entered into in December 2001, being recognized in the first quarter of fiscal year 2002 compared to only one month in the first quarter of fiscal year 2003. Revenues from research and development funding were $200,000 for the first quarter of fiscal year 2003 compared to $121,000 for the first quarter of fiscal year 2002.
Cost of product sales and services consists of material, labor and overhead. Cost of product sales and services was $35.4 million for the first quarter of fiscal year 2003 compared to $35.7 million for the first quarter of fiscal year 2002. Gross profit from product sales and services as a percentage of revenue from product sales and services increased to 13% in the first quarter of fiscal year 2003 from 10% in the first quarter of fiscal year 2002. This increase in the gross profit percentage was due to a decrease in crop sourcing costs as a percent of revenue in the first quarter of fiscal year 2003 as compared to the first quarter of fiscal year 2002. During the first quarter of fiscal year 2002, the Company incurred $2.5 million of incremental produce sourcing cost because of an industry-wide shortage of essential value-added produce items. These items had to be purchased at inflated prices on the open market in late December 2001 and most of January 2002 during the critical holiday season. The decrease in produce sourcing costs was partially offset by an increase in losses from farming activities to $789,000 in the first quarter of fiscal year 2003 as compared to losses of $133,000 in the same period last year. Overall, gross profits increased 22% to $5.7 million in the first quarter of fiscal year 2003 compared to $4.7 million in the first quarter of fiscal year 2002.
Research and development expenses increased to $1.1 million for the first quarter of fiscal year 2003 compared to $832,000 in the first quarter of fiscal year 2002, an increase of 29%. The increase in research and development expenses in the first quarter of fiscal year 2003 as compared to the first quarter 2002 is due to the Companys increased efforts in developing its banana packaging technology. Landecs research and development expenses consist primarily of expenses involved in the development of, process scale-up of, and efforts to protect intellectual property content of Landecs enabling side chain crystallizable polymer technology. The Company expects that total research and development spending in fiscal year 2003 will increase in comparison to the prior year in absolute dollars but may decrease as a percent of revenue as more products transition from research and development stages to commercialization.
Selling, general and administrative expenses were $6.5 million for the first quarter of fiscal year 2003 compared to $6.8 million for the first quarter of fiscal year 2002, a decrease of 4%. Selling, general and administrative expenses decreased in the first quarter of fiscal year 2003 as compared to the first quarter of 2002 primarily as a result of decreased general and administrative expenses at Apio from efficiencies derived from the new ERP system installed in fiscal year 2002. Selling, general and administrative expenses consist primarily of sales and marketing expenses associated with Landecs product sales and services, business development expenses, and staff and administrative expenses. Sales and marketing expenses decreased to $2.1 million for the first quarter of fiscal year 2003 from $2.3 million for the first quarter of fiscal year 2002. Landec expects that total selling, general and administrative spending for existing and newly acquired products will decrease in absolute dollars in future periods.
Interest income increased to $64,000 for the first quarter of fiscal year 2003 compared to $33,000 for the first quarter of fiscal year 2002. Interest expense decreased to $322,000 in the first quarter of fiscal year 2003 compared to $631,000 in the first quarter of fiscal year 2002.
16
Liquidity and Capital Resources
As of January 26, 2003, the Company had cash and cash equivalents of $5.3 million, or net decrease of $2.5 million from $7.8 million at October 27, 2002. This decrease was primarily due to: (a) the purchase of $808,000 of property and equipment; (b) the reduction of net borrowings under the Companys lines of credit of $2.0 million, and (c) the reduction of long term debt of $1.3 million; partially offset by net cash provided by operating activities of $1.0 million.
During the first quarter of fiscal year 2003, Landec purchased equipment to support the development of Apios value added products, and to upgrade Apios ERP business system. These expenditures represented the majority of the $808,000 of property and equipment purchased.
On October 31, 2002, Apios loan agreement with Bank of America was amended to extend the revolving line of credit through January 31, 2003 and to decrease the interest rate to prime plus 1.75%, or 6.00%, on an annual basis. The loan agreement was amended again in January 2003, and February 2003, resulting in the extension of the line of credit through May 1, 2003. The Company is currently negotiating a new working capital line of credit with its bank.
At January 26, 2003, Landecs total debt, including current maturities and capital lease obligations, was approximately $14.3 million and the total debt to equity ratio was approximately 26% as compared to 31% at October 27, 2002. Of this debt, approximately $8.1 million is comprised of revolving lines of credit and approximately $6.2 million is comprised of term debt and capital lease obligations, $2.3 million of which is mortgage debt on Apios manufacturing facilities. The amount of debt outstanding on Landecs revolving lines of credit fluctuates over time, and the agreements contain financial and other limiting covenants. Borrowings on Landecs lines of credit are expected to vary with seasonal requirements of the Companys businesses. In addition, in connection with Landecs acquisition of Apio, Landec is obligated to pay the former owners of Apio $2.5 million, which will be paid in fiscal years 2004 and 2005 and is recorded as long-term debt, and an additional $1.6 million, which will be paid in monthly payments beginning in May 2003 through February 2004. The Companys material contractual obligations for the next five years and thereafter as of January 26, 2003, are as follows (in thousands):
|
|
Due in Fiscal Year |
|
|||||||||||||||||||
Obligation |
|
Total |
|
Remainder |
|
2004 |
|
2005 |
|
2006 |
|
2007 |
|
Thereafter |
|
|||||||
Lines of Credit |
|
$ |
8,134 |
|
$ |
8,134 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
Long-term Debt |
|
4,964 |
|
103 |
|
1,301 |
|
1,351 |
|
144 |
|
128 |
|
1,937 |
|
|||||||
Capital Leases |
|
1,213 |
|
328 |
|
564 |
|
308 |
|
13 |
|
|
|
|
|
|||||||
Operating Leases |
|
1,019 |
|
301 |
|
586 |
|
106 |
|
26 |
|
|
|
|
|
|||||||
Land Leases |
|
172 |
|
172 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Earn-Out Liability |
|
1,601 |
|
109 |
|
1,492 |
|
|
|
|
|
|
|
|
|
|||||||
Licensing Obligation |
|
1,750 |
|
250 |
|
200 |
|
200 |
|
200 |
|
200 |
|
700 |
|
|||||||
Total |
|
$ |
18,853 |
|
$ |
9,397 |
|
$ |
4,143 |
|
$ |
1,965 |
|
$ |
383 |
|
$ |
328 |
|
$ |
2,637 |
|
Landec believes that its debt facilities, cash from operations, along with existing cash, cash equivalents and existing borrowing capacities will be sufficient to finance its operational and capital requirements through at least the next twelve months.
Landecs future capital requirements will depend on numerous factors, including the progress of its research and development programs; the development of commercial scale manufacturing capabilities; the development of marketing, sales and distribution capabilities; the ability of Landec to establish and maintain new collaborative and licensing arrangements; any decision to pursue additional acquisition opportunities; weather conditions that can affect the supply and price of produce, the timing and amount, if any, of payments received under licensing and research and development agreements; the costs involved in preparing, filing, prosecuting, defending and enforcing intellectual property rights; the ability to comply with regulatory requirements; the emergence of competitive technology and market forces; the effectiveness of product commercialization activities and arrangements; and other
17
factors. If Landecs currently available funds, together with the internally generated cash flow from operations are not sufficient to satisfy its capital needs, Landec would be required to seek additional funding through other arrangements with collaborative partners, additional bank borrowings and public or private sales of its securities. There can be no assurance that additional funds, if required, will be available to Landec on favorable terms if at all.
Additional Factors That May Affect Future Results
Landec desires to take advantage of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and of Section 21E and Rule 3b-6 under the Securities Exchange Act of 1934. Specifically, Landec wishes to alert readers that the following important factors, as well as other factors including, without limitation, those described elsewhere in this report, could in the future affect, and in the past have affected, Landecs actual results and could cause Landecs results for future periods to differ materially from those expressed in any forward-looking statements made by or on behalf of Landec. Landec assumes no obligation to update such forward-looking statements.
We Have a History of Losses Which May Continue
We have incurred net losses in each fiscal year since our inception. Our accumulated deficit as of January 26, 2003 totaled $61.4 million. We may incur additional losses in the future. The amount of future net profits, if any, is highly uncertain and we may never generate significant revenues or achieve profitability.
Our Substantial Indebtedness Could Limit Our Financial and Operating Flexibility
At January 26, 2003, our total debt, including current maturities and capital lease obligations, was approximately $14.3 million and the total debt to equity ratio was approximately 26 %. Of this debt, approximately $8.1 million is comprised of revolving lines of credit and approximately $6.2 million is comprised of term debt and capital lease obligations. The amount of debt outstanding on our revolving lines of credit fluctuates over time, and the agreements contain financial and other limiting covenants. All $8.1 million outstanding under the revolving lines of credit is due on May 1, 2003. Of our term debt and capital lease obligations, approximately $431,000 become due over the remainder of fiscal year 2003 and $1.9 million and $1.7 million become due in fiscal years 2004 and 2005, respectively. This level of indebtedness limits our financial and operating flexibility in the following ways:
a substantial portion of net cash flow from operations must be dedicated to debt service and will not be available for other purposes;
our ability to obtain additional debt financing in the future for working capital is reduced;
our ability to fund capital expenditures or acquisitions may be limited;
our ability to react to changes in the industry and economic conditions generally may be limited.
In connection with the Apio acquisition, we may be obligated to make future payments to the former shareholders of Apio of up to $4.1 million for a performance based earn out and future supply of produce. Of this amount, $1.6 million relates to the earn out from fiscal year 2000 that is due to be paid in periodic scheduled payments through February 2004 and $2.5 million relates to payments to be made in January 2004 and 2005.
Our ability to service this indebtedness and these future payments will depend on our future performance, which will be affected by prevailing economic conditions and financial, business and other factors, some of which are beyond our control. If we are unable to service this debt, we would be forced to pursue one or more alternative strategies such as selling assets, restructuring or refinancing our indebtedness or seeking additional equity capital, which might not be successful and which could substantially dilute the ownership interest of existing shareholders.
18
We Have Violated Restrictions in Our Loan Agreements and May Have to Pursue New Financings if We Are Unable to Comply with These Provisions in the Future
Apio is subject to various financial and operating covenants under its term debt and line of credit facilities (the Loan Agreement), including minimum fixed charge coverage ratio, minimum current ratio, minimum adjusted net worth and maximum leverage ratios. The Loan Agreement limits the ability of Apio to make cash payments to Landec. Landec Ag is subject to certain restrictive covenants in its loan agreements which limit the ability of Landec Ag to make payments on debt owed to Landec. We have pledged substantially all of Apios and Landec Ags assets to secure their bank debt. Although we are currently not in violation of any of the provisions of the Loan Agreement we have violated provisions of the Loan Agreement in the past. If we violate any obligations in the future we could trigger an event of default, which, if not cured or waived, would permit acceleration of our obligation to repay the indebtedness due under the Loan Agreement. If the indebtedness due under the Loan Agreement were accelerated, we would be forced to pursue one or more alternative strategies such as selling assets, seeking new debt financing from another lender or seeking additional equity capital, which might not be achievable or available on attractive terms, if at all, and which could substantially dilute the ownership interest of existing shareholders.
Our Future Operating Results Are Likely to Fluctuate Which May Cause Our Stock Price to Decline
In the past, our results of operations have fluctuated significantly from quarter to quarter and are expected to continue to fluctuate in the future. Historically, our direct marketer of hybrid corn seed, Landec Ag, has been the primary source of these fluctuations, as its revenues and profits are concentrated over a few months during the spring planting season (generally during our second quarter). In addition, Apio can be heavily affected by seasonal and weather factors which have impacted quarterly results, such as the high cost of sourcing product during the first quarter of fiscal year 2002 due to a shortage of essential value-added produce items which had to be purchased at inflated prices on the open market in December 2001 and January 2002. Our earnings may also fluctuate based on our ability to collect accounts receivables from customers and note receivables from growers. Our earnings from our Food Products Technology business are sensitive to price fluctuations in the fresh vegetables and fruits markets. Excess supplies can cause intense price competition. Other factors that affect our food and/or agricultural operations include:
the seasonality of our supplies;
our ability to process produce during critical harvest periods;
the timing and effects of ripening;
the degree of perishability;
the effectiveness of worldwide distribution systems;
total worldwide industry volumes;
the seasonality of consumer demand;
foreign currency fluctuations; and
foreign importation restrictions and foreign political risks.
As a result of these and other factors, we expect to continue to experience fluctuations in quarterly operating results, and we may never reach or sustain profitability for an entire fiscal year.
We May Not Be Able to Achieve Acceptance of Our New Products in the Marketplace
Our success in generating significant sales of our products will depend in part on the ability of us and our partners and licensees to achieve market acceptance of our new products and technology. The extent to which, and rate at which, we achieve market acceptance and penetration of our current and future products is a function of many variables including, but not limited to:
price;
19
safety;
efficacy;
reliability;
conversion costs;
marketing and sales efforts; and
general economic conditions affecting purchasing patterns.
We may not be able to develop and introduce new products and technologies in a timely manner or new products and technologies may not gain market acceptance. We are in the early stage of product commercialization of certain breathable membrane, Intellicoat seed coating and other Intelimer polymer products and many of our potential products are in development. We believe that our future growth will depend in large part on our ability to develop and market new products in our target markets and in new markets. In particular, we expect that our ability to compete effectively with existing food products, agricultural, industrial and medical companies will depend substantially on successfully developing, commercializing, achieving market acceptance of and reducing the cost of producing our products. In addition, commercial applications of our temperature switch polymer technology are relatively new and evolving. Our failure to develop new products or the failure of our new products to achieve market acceptance would have a material adverse effect on our business, results of operations and financial condition.
We Face Strong Competition in the Marketplace
Competitors may succeed in developing alternative technologies and products that are more effective, easier to use or less expensive than those which have been or are being developed by us or that would render our technology and products obsolete and non-competitive. We operate in highly competitive and rapidly evolving fields, and new developments are expected to continue at a rapid pace. Competition from large food products, agricultural, industrial and medical companies is expected to be intense. In addition, the nature of our collaborative arrangements may result in our corporate partners and licensees becoming our competitors. Many of these competitors have substantially greater financial and technical resources and production and marketing capabilities than we do, and may have substantially greater experience in conducting clinical and field trials, obtaining regulatory approvals and manufacturing and marketing commercial products.
We Have Limited Manufacturing Experience and Concentration of Capacity in One Location for Apio and May Have to Depend on Third Parties to Manufacture Our Products
Any disruptions in our primary manufacturing operation would reduce our ability to sell our products and would have a material adverse effect on our financial results. Additionally, we may need to consider seeking collaborative arrangements with other companies to manufacture our products. If we become dependent upon third parties for the manufacture of our products, our profit margins and our ability to develop and deliver those products on a timely basis may be affected. Failures by third parties may impair our ability to deliver products on a timely basis and impair our competitive position. We may not be able to continue to successfully operate our manufacturing operations at acceptable costs, with acceptable yields, and retain adequately trained personnel.
Our Dependence on Single-Source Suppliers and Service Providers May Cause Disruption in Our Operations Should Any Supplier Fail to Deliver Materials
We may experience difficulty acquiring materials or services for the manufacture of our products or we may not be able to obtain substitute vendors. We may not be able to procure comparable materials or hybrid corn varieties at similar prices and terms within a reasonable time. Several services that are provided to Apio are obtained from a single provider. Several of the raw materials we use to manufacture our products are currently purchased from a single source, including some monomers used to synthesize Intelimer polymers and substrate materials for our breathable membrane products. In addition, virtually all of the hybrid corn varieties sold by Landec Ag are sourced from a single seed producer. Any interruption of our relationship with single-source suppliers or service providers could delay product shipments and materially harm our business.
20
We May Be Unable to Adequately Protect Our Intellectual Property Rights
We have received, and may in the future receive, from third parties, including some of our competitors, notices claiming that we are infringing their patents or other proprietary rights. If we were determined to be infringing any third-party patent, we could be required to pay damages, alter our products or processes, obtain licenses or cease the infringing activities. If we are required to obtain any licenses, we may not be able to do so on commercially favorable terms, if at all. Litigation, which could result in substantial costs to and diversion of our efforts, may also be necessary to enforce any patents issued or licensed to us or to determine the scope and validity of third-party proprietary rights. Any litigation or interference proceeding, regardless of outcome, could be expensive and time consuming and could subject us to significant liabilities to third parties, require disputed rights to be licensed from third parties or require us to cease using that technology. Our success depends in large part on our ability to obtain patents, maintain trade secret protection and operate without infringing on the proprietary rights of third parties. Any pending patent applications we file may not be approved and we may not be able to develop additional proprietary products that are patentable. Any patents issued to us may not provide us with competitive advantages or may be challenged by third parties. Patents held by others may prevent the commercialization of products incorporating our technology. Furthermore, others may independently develop similar products, duplicate our products or design around our patents.
Our Operations Are Subject to Regulations that Directly Impact Our Business
Our food packaging products are subject to regulation under the FDC Act. Under the FDC Act, any substance that when used as intended may reasonably be expected to become, directly or indirectly, a component or otherwise affect the characteristics of any food may be regulated as a food additive unless the substance is generally recognized as safe. We believe that food packaging materials are generally not considered food additives by the FDA because these products are not expected to become components of food under their expected conditions of use. We consider our breathable membrane product to be a food packaging material not subject to regulation or approval by the FDA. We have not received any communication from the FDA concerning our breathable membrane product. If the FDA were to determine that our breathable membrane products are food additives, we may be required to submit a food additive petition for approval by the FDA. The food additive petition process is lengthy, expensive and uncertain. A determination by the FDA that a food additive petition is necessary would have a material adverse effect on our business, operating results and financial condition.
Federal, state and local regulations impose various environmental controls on the use, storage, discharge or disposal of toxic, volatile or otherwise hazardous chemicals and gases used in some of the manufacturing processes. Our failure to control the use of, or to restrict adequately the discharge of, hazardous substances under present or future regulations could subject us to substantial liability or could cause our manufacturing operations to be suspended and changes in environmental regulations may impose the need for additional capital equipment or other requirements.
Our agricultural operations are subject to a variety of environmental laws including, the Food Quality Protection Act of 1966, the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act, the Federal Insecticide, Fungicide and Rodenticide Act, and the Comprehensive Environmental Response, Compensation and Liability Act. Compliance with these laws and related regulations is an ongoing process. Environmental concerns are, however, inherent in most agricultural operations, including those we conduct. Moreover, it is possible that future developments, such as increasingly strict environmental laws and enforcement policies could result in increased compliance costs.
The Company is subject to the Perishable Agricultural Commodities Act (PACA) law. PACA regulates fair trade standards in the fresh produce industry and governs all the product sold by Apio. Our failure to comply with the PACA requirements could among other things, result in civil penalties, suspension or revocation of a license to sell produce, and in the most egregious cases, criminal prosecution, which could have a material adverse affect on our business.
21
Adverse Weather Conditions and Other Acts of God May Cause Substantial Decreases in Our Sales and/or Increases in Our Costs
Our Food Products and Agricultural Seed Technology businesses are subject to weather conditions that affect commodity prices, crop yields, and decisions by growers regarding crops to be planted. Crop diseases and severe conditions, particularly weather conditions such as floods, droughts, frosts, windstorms and hurricanes, may adversely affect the supply of vegetables and fruits used in our business, which could reduce the sales volumes and/or increase the unit production costs. Because a significant portion of the costs are fixed and contracted in advance of each operating year, volume declines due to production interruptions or other factors could result in increases in unit production costs which could result in substantial losses and weaken our financial condition.
We Depend on Strategic Partners and Licenses for Future Development
Our strategy for development, clinical and field testing, manufacture, commercialization and marketing for some of our current and future products includes entering into various collaborations with corporate partners, licensees and others. We are dependent on our corporate partners to develop, test, manufacture and/or market some of our products. Although we believe that our partners in these collaborations have an economic motivation to succeed in performing their contractual responsibilities, the amount and timing of resources to be devoted to these activities are not within our control. Our partners may not perform their obligations as expected or we may not derive any additional revenue from the arrangements. Our partners may not pay any additional option or license fees to us or may not develop, market or pay any royalty fees related to products under the agreements. Moreover, some of the collaborative agreements provide that they may be terminated at the discretion of the corporate partner, and some of the collaborative agreements provide for termination under other circumstances. In addition, we may not receive any royalties on future sales of QuickCast and PORT products because we no longer have control over the sales of those products. Our partners may pursue existing or alternative technologies in preference to our technology. Furthermore, we may not be able to negotiate additional collaborative arrangements in the future on acceptable terms, if at all, and our collaborative arrangements may not be successful.
Both Domestic and Foreign Government Regulations Can Have an Adverse Effect on Our Business Operations
Our products and operations are subject to governmental regulation in the United States and foreign countries. The manufacture of our products is subject to periodic inspection by regulatory authorities. We may not be able to obtain necessary regulatory approvals on a timely basis or at all. Delays in receipt of or failure to receive approvals or loss of previously received approvals would have a material adverse effect on our business, financial condition and results of operations. Although we have no reason to believe that we will not be able to comply with all applicable regulations regarding the manufacture and sale of our products and polymer materials, regulations are always subject to change and depend heavily on administrative interpretations and the country in which the products are sold. Future changes in regulations or interpretations relating to matters such as safe working conditions, laboratory and manufacturing practices, environmental controls, and disposal of hazardous or potentially hazardous substances may adversely affect our business.
We are subject to USDA rules and regulations concerning the safety of the food products handled and sold by Apio, and the facilities in which they are packed and processed. Failure to comply with the applicable regulatory requirements can, among other things, result in:
fines, injunctions, civil penalties, and suspensions,
withdrawal of regulatory approvals,
product recalls and product seizures, including cessation of manufacturing and sales,
operating restrictions, and
criminal prosecution.
We may be required to incur significant costs to comply with the laws and regulations in the future which may have a material adverse effect on our business, operating results and financial condition.
22
Our International Operations and Sales May Expose Our Business to Additional Risks
For the first quarter of fiscal year 2003, approximately 20% of our total revenues were derived from product sales to international customers. A number of risks are inherent in international transactions. International sales and operations may be limited or disrupted by any of the following:
regulatory approval process,
government controls,
export license requirements,
political instability,
price controls,
trade restrictions,
changes in tariffs, or
difficulties in staffing and managing international operations.
Foreign regulatory agencies have or may establish product standards different from those in the United States, and any inability to obtain foreign regulatory approvals on a timely basis could have a material adverse effect on our international business, and our financial condition and results of operations. While our foreign sales are currently priced in dollars, fluctuations in currency exchange rates, may reduce the demand for our products by increasing the price of our products in the currency of the countries to which the products are sold. Regulatory, geopolitical and other factors may adversely impact our operations in the future or require us to modify our current business practices.
Cancellations or Delays of Orders by Our Customers May Adversely Affect Our Business
During the first quarter of fiscal year 2003, sales to our top five customers accounted for approximately 42 % of our revenues, with our top customers, Wal-Mart Stores Inc., accounting for approximately 19 % and Costco Wholesale Corp., accounting for approximately 13 % of our revenues. We expect that, for the foreseeable future, a limited number of customers may continue to account for a substantial portion of our net revenues. We may experience changes in the composition of our customer base, as Apio and Landec Ag have experienced in the past. We do not have long-term purchase agreements with any of our customers. The reduction, delay or cancellation of orders from one or more major customers for any reason or the loss of one or more of our major customers could materially and adversely affect our business, operating results and financial condition. In addition, since some of the products processed by Apio at its Guadalupe, California facility are often sole sourced to its customers, our operating results could be adversely affected if one or more of our major customers were to develop other sources of supply. Our current customers may not continue to place orders, orders by existing customers may be canceled or may not continue at the levels of previous periods or we may not be able to obtain orders from new customers.
Our Sale of Some Products May Increase Our Exposure to Product Liability Claims
The testing, manufacturing, marketing, and sale of the products we develop involves an inherent risk of allegations of product liability. If any of our products were determined or alleged to be contaminated or defective or to have caused a harmful accident to an end-customer, we could incur substantial costs in responding to complaints or litigation regarding our products and our product brand image could be materially damaged. Either event may have a material adverse effect on our business, operating results and financial condition. Although we have taken and intend to continue to take what we believe are appropriate precautions to minimize exposure to product liability claims, we may not be able to avoid significant liability. We currently maintain product liability insurance with limits in the amount of $41.0 million per occurrence and $42.0 million in the annual aggregate. Our coverage may not be adequate or may not continue to be available at an acceptable cost, if at all. A product liability claim, product recall or other claim with respect to uninsured liabilities or in excess of insured liabilities could have a material adverse effect on our business, operating results and financial condition.
23
Our Stock Price May Fluctuate in Accordance with Market Conditions
The stock market in general has recently experienced extreme price and volume fluctuations. The following events may cause the market price of our common stock to fluctuate significantly:
technological innovations applicable to our products,
our attainment of (or failure to attain) milestones in the commercialization of our technology,
our development of new products or the development of new products by our competitors,
new patents or changes in existing patents applicable to our products,
our acquisition of new businesses or the sale or disposal of a part of our businesses,
development of new collaborative arrangements by us, our competitors or other parties,
changes in government regulations applicable to our business,
changes in investor perception of our business,
fluctuations in our operating results and
changes in the general market conditions in our industry.
These broad fluctuations may adversely affect the market price of our common stock.
We Are Continuing to Implement a New Information System at Apio, and Problems with the Design or Implementation of this New System Could Interfere with Our Operations
We are in the process of implementing a new management information and accounting system at Apio to replace the old system, which was largely based on legacy systems that were created prior to our acquisition of Apio in 1999. As a part of this effort, we are implementing new enterprise resource planning software and other software applications to manage our business operations. We may not be successful in implementing these new systems and transitioning data. Although we believe that we have identified, to a large extent, the problems associated with the implementation and that the system is stable, problems could arise that we have not foreseen. During 2003, we expect to complete the implementation of the new system. If disruptions occur in the implementation and functionality in 2003, our operations could be interrupted. Such disruptions could adversely impact Apios ability to do the following in a timely manner: provide quotes, take customer orders, ship products, provide services and support to our customers, bill and track our customers, fulfill contractual obligations and otherwise run Apios business. In addition, the disruption caused by the implementation of such a system could prevent Apio from accumulating, recording, summarizing, processing and reporting the information to be disclosed by Landec in its periodic reports with the Securities and Exchange Commission in a timely manner. As a result, our financial position, results of operations, cash flows and stock price could be adversely affected.
Since We Order Cartons for Our Products from Suppliers in Advance of Receipt of Customer Orders for Such Products, We Could Face a Material Inventory Risk
As part of our inventory planning, we enter into negotiated orders with vendors of cartons used for packing our products in advance of receiving customer orders for such products. Accordingly, we face the risk of ordering too many cartons since orders are generally based on forecasts of customer orders rather than actual orders. If we cannot change or be released from the orders, we may incur costs as a result of inadequately predicting cartons orders in advance of customer orders. Because of this, we may currently have an oversupply of cartons and face the risk of not being able to sell such inventory and our anticipated reserves for losses may be inadequate if we have misjudged the demand for our products. Our business and operating results could be adversely affected as a result of these increased costs.
24
Our Seed Products May Fail to Germinate Properly and We May Be Subject to Claims for Reimbursement or Damages for Losses from Customers Who Use Such Products
Farmers plant seed products sold by Landec Ag with the expectation that they will germinate under normal growing conditions. If our seed products do not germinate at the appropriate time or fail to germinate at all, our customers may incur significant crop losses and seek reimbursement or bring claims against us for such damages. Although insurance is generally available to cover such claims, the costs for premiums of such policies are prohibitively expensive and we currently do not maintain such insurance. Any claims brought for failure of our seed products to properly germinate could materially and adversely effect our operating and financial results.
Recently Enacted and Proposed Changes in Securities Laws and Regulations Are Likely to Increase Our Costs
The Sarbanes-Oxley Act of 2002 (the Act) that became law in July 2002 requires changes in some of our corporate governance, public disclosure and compliance practices. The Act also requires the SEC to promulgate new rules on a variety of subjects. In addition to final rules and rules already made, Nasdaq has proposed revisions to its requirements for companies, such as Landec, that are listed on the NASDAQ. We expect these developments to increase our legal and financial compliance costs. We expect these changes to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These developments could make it more difficult for us to attract and retain qualified members for our board of directors, particularly to serve on our audit committee. We are presently evaluating and monitoring regulatory developments and cannot estimate the timing or magnitude of additional costs we may incur as a result of the Act.
Our Controlling Shareholders Exert Significant Influence over Corporate Events that May Conflict with the Interests of Other Shareholders
Our executive officers and directors and their affiliates own or control approximately 30% of our common stock (assuming conversion of outstanding preferred stock and including options exercisable within 60 days). Accordingly, these officers, directors and shareholders may have the ability to exert significant influence over the election of our Board of Directors, the approval of amendments to our articles and bylaws and the approval of mergers or other business combination transactions requiring shareholder approval. This concentration of ownership may have the effect of delaying or preventing a merger or other business combination transaction, even if the transaction or amendments would be beneficial to our other shareholders. In addition, our controlling shareholders may approve amendments to our articles or bylaws to implement anti-takeover or management friendly provisions that may not be beneficial to our other shareholders.
Terrorist Attacks and Risk of Contamination May Negatively Impact All Aspects of Our Operations, Revenues, Costs and Stock Price.
The September 2001 terrorist attacks in the United States, as well as future events occurring in response or connection to them, including, future terrorist attacks against United States targets, rumors or threats of war, actual conflicts involving the United States or its allies, or trade disruptions impacting our domestic suppliers or our customers, may impact our operations and may, among other things, cause decreased sales of our products. More generally, these events have affected, and are expected to continue to affect, the general economy and customer demand for our products. While we do not believe that our employees, facilities, or products are a target for terrorists, there is a remote risk that terrorist activities could result in contamination or adulteration of our products. Although we have systems and procedures in place that are designed to prevent contamination and adulteration of our products, a disgruntled employee or third party could introduce an infectious substance into packages of our products, either at our manufacturing plants or during shipment of our products. Were our products to be tampered with, we could experience a material adverse effect in our business, operations and financial condition.
Our Operating Results and Financial Condition Could Be Harmed if the Current Economic Downturn Continues
Any further decline in general economic conditions could result in a reduction in demand for our products. Such decline could harm our financial position, results of operations, cash flows and stock price, and could limit our
25
ability to reach our goals for achieving profitability. Also, in such an environment, pricing pressures could continue, and if we are unable to respond quickly enough this could negatively impact our gross margins.
We May Be Exposed to Employment Related Claims and Costs that Could Materially Adversely Affect Our Business
We have been subject in the past, and may be in the future, to claims by employees based on allegations of discrimination, negligence, harassment and inadvertent employment of illegal aliens or unlicensed personnel, and we may be subject to payment of workers compensation claims and other similar claims. We could incur substantial costs and our management could spend a significant amount of time responding to such complaints or litigation regarding employee claims, which may have a material adverse effect on our business, operating results and financial condition.
We Are Dependent on Our Key Employees and if One or More of Them Were to Leave, We Could Experience Difficulties in Replacing Them and Our Operating Results Could Suffer
The success of our business depends to a significant extent upon the continued service and performance of a relatively small number of key senior management, technical, sales, and marketing personnel. The loss of any of our key personnel would likely harm our business. In addition, competition for senior level personnel with knowledge and experience in our different line of business is intense. If any of our key personnel were to leave, we would need to devote substantial resources and management attention to replace them. As a result, management attention may be diverted from managing our business, and we may need to pay higher compensation to replace these employees.
We May Issue Preferred Stock with Preferential Rights that Could Affect Your Rights
Our Board of Directors has the authority, without further approval of our shareholders, to fix the rights and preferences, and to issue shares, of preferred stock. In November, 1999 we issued and sold shares of Series A Convertible Preferred Stock and in October 2001 we issued and sold shares of Series B Convertible Preferred Stock. The Series A Convertible Preferred Stock was converted into 1,666,670 shares of Common Stock on November 19, 2002. Each share of Series B Convertible Preferred Stock is convertible into shares of common stock in accordance with the conversion formula provided in our articles of incorporation (currently a 10:1 ratio) and is entitled to the number of votes equal to the number of shares of Common Stock into which such shares could be converted.
Holders of Series B Convertible Preferred Stock have the following preferential rights over holders of common stock:
Dividend Preference: Holders of Series B Convertible Preferred Stock are entitled to cumulative dividends payable in additional shares of Series B Convertible Preferred Stock at an annual rate of eight percent (8%) for the first two years, ten percent (10%) for the third year and twelve percent (12%) thereafter, following the initial sale on October 25, 2001 of shares of Series B Convertible Preferred Stock.
Liquidation Preference: Upon liquidation of the Company, holders of Series B Convertible Preferred Stock are entitled to receive, in preference to the holders of common stock, an amount equal to the original issue price of their shares plus any declared or accrued but unpaid dividends.
The issuance of additional shares of preferred stock could have the effect of making it more difficult for a third party to acquire a majority of our outstanding stock, and the holders of such preferred stock could have voting, dividend, liquidation and other rights superior to those of holders of our Common Stock.
We Have Never Paid any Dividends on Our Common Stock
We have not paid any cash dividends on our Common Stock since inception and do not expect to do so in the foreseeable future. Any dividends will be subject to the preferential dividends payable on our outstanding Series B Preferred Stock and dividends payable on any other preferred stock we may issue.
26
The Reporting of Our Profitability Could Be Materially And Adversely Affected if it Is Determined that the Book Value of Goodwill is Higher than Fair Value
Our balance sheet includes an amount designated as goodwill that represents a portion of our assets and our stockholders equity. Goodwill arises when an acquirer pays more for a business than the fair value of the tangible and separately measurable intangible net assets. Under a newly issued accounting pronouncement, Statement of Financial Accounting Standards No. 142 Goodwill and Other Intangible Assets, beginning in fiscal year 2002, the amortization of goodwill has been replaced with an impairment test which requires that we compare the fair value of goodwill to its book value at least annually and more frequently if circumstances indicate a possible impairment. If we determine at any time in the future that the book value of goodwill is higher than fair value then the difference must be written-off, which could materially and adversely affect our profitability.
27
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There has been no material change in the Companys reported market risks since the end of fiscal year 2002.
Item 4. Controls and Procedures
(a) Based on their evaluation as of a date within 90 days of the filing date of this Quarterly Report on Form 10-Q (the "Evaluation Date"), Landec's principal executive officer and principal financial officer concluded that, as of the Evaluation Date, Landec's disclosure controls and procedures as defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") were effective such that the material information required to be disclosed by Landec in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
(b) Since the Evaluation Date, there have not been any significant changes in Landec's internal controls or in other factors that could significantly affect these controls, including any corrective actions with regard to significant deficiencies and material weaknesses.
28
Item 1. Legal Proceedings
None.
Item 2. Changes in Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None.
Item 4. Submission of Matters to a Vote of Security Holders
None.
Item 5. Other Information
(a) Audit Committee Approval of Non-Audit Services
In accordance with Section 10A(i)(2) of the Securities Exchange Act of 1934, as added by Section 202 of the Sarbanes-Oxley Act of 2002 (the Act), we are required to disclose the non-audit services approved by our Audit Committee to be performed by Ernst & Young LLP, our independent accountants. Non-audit services are defined in the Act as services other than those provided in connection with an audit or a review of the financial statements of a company. On February 20, 2003, the Audit Committee approved the engagement of Ernst & Young LLP for the following non-audit services: (1) tax matter consultations and compliance and (2) the preparation of federal and state income tax returns for fiscal year 2002.
(b) Change in Fiscal Year
As a result of the change in the Companys fiscal year from a fiscal year including 52 or 53 weeks that ends on the last Sunday in October to a fiscal year including 52 or 53 weeks that ends on the last Sunday in May, the Company expects to hold its next annual meeting of shareholders in October 2003, rather than April 2004.
Proposals of shareholders of the Company that are intended to be presented by such shareholders at the October 2003 annual meeting of shareholders must be received by the Chief Financial Officer of the Company no later than May 25, 2003, in order that they may be considered for inclusion in the proxy statement and form of proxy relating to that meeting. Also, if a shareholder does not notify the Chief Financial Officer of the Company on or before August 11, 2003 of a proposal for the October 2003 annual meeting of shareholders, management intends to use its discretionary voting authority to vote on such proposal, even if the matter is not discussed in the proxy statement for the October 2003 annual meeting of shareholders.
29
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits.
Exhibit |
|
Exhibit Title |
|
|
|
10.39(1) |
|
Amendment No. 9 to Loan Agreement between Apio, Inc. and the Bank of America dated as of October 31, 2002. |
|
|
|
10.40(1) |
|
Amendment No. 2 to the Purchase Agreement between the Registrant and Apio, Inc. dated December 17, 2002. |
|
|
|
10.41+ |
|
Amendment No. 10 to Loan Agreement between Apio, Inc. and the Bank of America dated as of January 15, 2003. |
|
|
|
10.42+ |
|
Amendment No. 11 to Loan Agreement between Apio, Inc. and the Bank of America dated as of January 30, 2003. |
|
|
|
10.43+ |
|
Amendment No. 12 to Loan Agreement between Apio, Inc. and the Bank of America dated as of February 28, 2003. |
|
|
|
99.1+ |
|
CEO Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
99.2+ |
|
CFO Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002. |
+ Filed herewith.
(1) Incorporated by reference to identically numbered exhibits filed with the Registrants Form 10-K filed for the fiscal year ended October 27, 2002.
(b) Reports on Form 8-K
A report on Form 8-K was filed on November 7, 2002 reporting the sale of all of the stock of Dock Resins Corporation to The Lubrizol Corporation on October 24, 2002.
30
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
LANDEC CORPORATION |
|||
|
|
|||
|
|
|||
|
By: |
/s/ |
Gregory S. Skinner |
|
|
|
Gregory S. Skinner |
||
|
|
Vice President of Finance and Administration and
Chief Financial Officer |
||
|
|
|||
|
|
|||
Date: March 11, 2003 |
|
31
CERTIFICATIONS
I, Gary T. Steele, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Landec Corporation;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
(a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
(b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and
(c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
(a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
6. The registrants other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: March 11, 2003
/s/ Gary T. Steele |
|
Gary T. Steele |
|
President and Chief Executive Officer |
32
I, Gregory S. Skinner, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Landec Corporation;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
(a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
(b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and
(c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
(a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
6. The registrants other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: March 11, 2003
/s/ Gregory S. Skinner |
|
Gregory S. Skinner |
|
Vice President of Finance
and Administration |
33
Exhibit |
|
Exhibit |
|
|
|
|
|
|
|
10.41 |
|
Amendment No. 10 to Loan Agreement between Apio, Inc. and the Bank of America dated as of January 15, 2003. |
|
|
|
|
|
|
|
10.42 |
|
Amendment No. 11 to Loan Agreement between Apio, Inc. and the Bank of America dated as of January 30, 2003. |
|
|
|
|
|
|
|
10.43 |
|
Amendment No. 12 to Loan Agreement between Apio, Inc. and the Bank of America dated as of February 28, 2003. |
|
|
|
|
|
|
|
99.1 |
|
CEO Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
99.2 |
|
CFO Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
34